CCAP logo

Crescent Capital BDC (CCAP) Stock

Profile

Country:

United States

IPO:

03 February 2020

Indexes:

Not included

Description:

Crescent Capital BDC (CCAP) is a business development company that provides financing solutions to middle-market companies. It focuses on private debt investments, including senior secured loans and subordinated debt, aiming to generate attractive risk-adjusted returns for its investors while supporting business growth.

Key Details

Price

$19.29

TTM Dividend Yield

10.58%(+0.76% YoY)

PE Ratio

7.54(+0.53% YoY)

Beta

0.51

Events Calendar

Earnings

Next earnings date:

Feb 21, 2025

Recent quarterly earnings:

Nov 11, 2024

Recent annual earnings:

Feb 21, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

Dec 31, 2024
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

25 Nov '24 Keefe, Bruyette & Woods
Outperform
30 Sept '24 Ladenburg Thalmann
Buy
15 Aug '24 B of A Securities
Buy
14 Aug '24 Wells Fargo
Equal-Weight
26 July '24 Wells Fargo
Equal-Weight
23 May '24 Keefe, Bruyette & Woods
Outperform
13 May '24 Wells Fargo
Equal-Weight
10 May '24 Raymond James
Outperform
23 Feb '24 Oppenheimer
Outperform
29 Jan '24 Wells Fargo
Equal-Weight

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Efficiency

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Institutional Ownership

Crescent Capital's Outstanding Dividend Coverage Makes It A Buy
Crescent Capital's Outstanding Dividend Coverage Makes It A Buy
Crescent Capital's Outstanding Dividend Coverage Makes It A Buy
CCAP
seekingalpha.com19 December 2024

CCAP is a defensive BDC with a 90% concentration on first-lien debt, ensuring high repayment priority during potential litigation processes. The portfolio focuses on non-cyclical businesses (85%), providing safety and predictability of cash flows, and the median EBITDA of its portfolio companies amounts to $27m. CCAP offers substantial distributions, including a $0.42 quarterly dividend per share and additional supplemental distributions, making it an attractive income holding.

Crescent Capital BDC : Material Agreement Form 8 K
Crescent Capital BDC : Material Agreement Form 8 K
Crescent Capital BDC : Material Agreement Form 8 K
CCAP
https://www.marketscreener.com06 December 2024

Item 1.01. Entry into a Material Definitive Agreement On December 3, 2024, Crescent Capital BDC, Inc. (the "Company") and certain subsidiaries of the Company entered into an Amended and Restated Senior Secured Revolving Credit Agreement (the "Revolving Credit Agreement") with Sumitomo Mitsui Banking Corporation as Administrative Agent ("Agent"), Collateral Agent, Lead Arranger, Sole Bookrunner and a lender, and certain other lenders named therein. aAdsList.push('Article'); aAdsListSize.push([300, 250]); aAdsListCA.push(null); The Revolving Credit Agreement amended and restated an existing Senior Secured Revolving Credit Agreement with Agent and, among other things, (i) decreased the size of the aggregate revolving commitment from up to $350,000,000.00 to up to $285,000,000.00, (ii) added an initial term commitment in an amount not to exceed $25,000,000.00 for an aggregate facility size of $310,000,000.00, (iii) increased the interest rate by 0.125% so that borrowings under the revolving commitment will bear interest at the applicable benchmark rate plus (A) 1.125% per annum for ABR Loans and 2.125% per annum for Term Benchmark Loans and RFR Loans if the Borrowing Base is less than 1.60 times the Combined Debt Amount and (B) 1.000% per annum for ABR Loans and 2.000% for Term Benchmark Loans and RFR Loans if the Borrowing Base is equal to or greater than 1.60 times the Combined Debt Amount, in each case, on outstanding amounts, or as otherwise determined by the Revolving Credit Agreement, (iii) extended the facility termination date from October 27, 2026 to December 3, 2029, unless otherwise terminated earlier under the Revolving Credit Agreement, and (iv) extended the facility revolving commitment period termination date from October 27, 2025, to December 1, 2028, unless otherwise terminated earlier under the Revolving Credit Agreement. Borrowings under the Revolving Credit Agreement remain subject to leverage restrictions contained in the Investment Company Act of 1940, as amended. The description above is only a summary of the material, amended provisions of the Revolving Credit Agreement and is qualified in its entirety by reference to a copy of the Revolving Credit Agreement, which is filed as Exhibit 10.1 to this current report on Form 8-K.Attachments Original document Permalink DisclaimerCrescent Capital BDC Inc. published this content on December 06, 2024, and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on December 06, 2024 at 11:02:02.990.

I'm Buying Up To 9% Yield For Recurring Income
I'm Buying Up To 9% Yield For Recurring Income
I'm Buying Up To 9% Yield For Recurring Income
CCAP
seekingalpha.com02 December 2024

Inflation makes Crescent Capital and Crown Castle compelling income-generating investments with yields of 9% and 6%, respectively. Crescent Capital offers a diversified portfolio with a strong 1st lien loan focus, high dividend coverage, and potential for capital appreciation. Crown Castle benefits from growing data demand and AI trends, providing essential infrastructure with a solid balance sheet and attractive valuation.

Crescent Capital: Q3 Earnings Reinforce Strong Total Return Potential
Crescent Capital: Q3 Earnings Reinforce Strong Total Return Potential
Crescent Capital: Q3 Earnings Reinforce Strong Total Return Potential
CCAP
seekingalpha.com13 November 2024

Crescent Capital's strong dividend coverage and NAV growth indicate a resilient portfolio. The current dividend yield is 9.7% and is well supported by earnings. The portfolio, valued at $1.6B, is concentrated in health care and software, with 97% of debt investments on a floating rate basis. The rate of non-accruals still remains low, showing portfolio company resilience. This highlights CCAP's high-quality underwriting and financial health.

Why Crescent Capital BDC (CCAP) Could Beat Earnings Estimates Again
Why Crescent Capital BDC (CCAP) Could Beat Earnings Estimates Again
Why Crescent Capital BDC (CCAP) Could Beat Earnings Estimates Again
CCAP
zacks.com14 October 2024

Crescent Capital BDC (CCAP) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

2 Small Cap, Growing BDCs That Could Be Great Income Additions To Your Portfolio
2 Small Cap, Growing BDCs That Could Be Great Income Additions To Your Portfolio
2 Small Cap, Growing BDCs That Could Be Great Income Additions To Your Portfolio
CCAP
seekingalpha.com11 October 2024

Income investors should consider Crescent Capital BDC and Fidus Investment for their portfolios, as both trade below Net Asset Values and offer growth potential. CCAP, despite a short track record, shows strong investment activity, solid balance sheet, and consistent dividend payouts, making it a defensively positioned growth opportunity. FDUS has a longer track record, impressive dividend growth, and a solid balance sheet with a lower leverage ratio, offering stability and income reliability.

I'm Buying Up To 9% Yield For Recurring Income
I'm Buying Up To 9% Yield For Recurring Income
I'm Buying Up To 9% Yield For Recurring Income
CCAP
seekingalpha.com24 September 2024

An investor's cash flow should be measured alongside net worth as a measure of financial resiliency. Crescent Capital offers an 8.9% yield, focusing on first-lien loans in cash flow-generating, private equity-backed middle-market businesses, with a robust portfolio and strong financials. Federal Realty, a top-tier REIT, provides a 3.9% yield, high-quality mixed-use properties in affluent areas, and a 57-year streak of dividend increases.

Crescent Capital High Yielding Dividends Are Well-Covered Despite Interest Rate Sensitivity
Crescent Capital High Yielding Dividends Are Well-Covered Despite Interest Rate Sensitivity
Crescent Capital High Yielding Dividends Are Well-Covered Despite Interest Rate Sensitivity
CCAP
seekingalpha.com18 September 2024

Crescent Capital BDC has a well-diversified, defensive portfolio with 89.2% first-lien debt and decreasing non-accruals, indicating high portfolio quality. CCAP is sensitive to interest rate cuts due to its floating-rate debt investments, but lower interest expenses and increased market activity could somewhat offset this. Despite potential interest rate cuts, CCAP's dividends remain well-covered, with a strong net investment income per share providing robust dividend coverage.

Buy These ‘Private Equity' Plays For 10.5% Yields
Buy These ‘Private Equity' Plays For 10.5% Yields
Buy These ‘Private Equity' Plays For 10.5% Yields
CCAP
forbes.com15 September 2024

Let's talk about a “rich guy loophole” that you and I can take advantage of—and bank dividends up to 12.5%.

Crescent Capital: Strong Cash Flow And The Right Quality For Remaining Bullish
Crescent Capital: Strong Cash Flow And The Right Quality For Remaining Bullish
Crescent Capital: Strong Cash Flow And The Right Quality For Remaining Bullish
CCAP
seekingalpha.com25 August 2024

Recently, Crescent Capital has outperformed the BDC market delivering positive returns, while the index has dropped in the negative return territory. Q2, 2024 earnings deck helps explain this, where we can see a continued generation of robust cash flows, solid portfolio quality and improved transaction outlook. In this article, I dissect the Q2 earnings and explain in detail why I have remained bullish.

FAQ

  • What is the primary business of Crescent Capital BDC?
  • What is the ticker symbol for Crescent Capital BDC?
  • Does Crescent Capital BDC pay dividends?
  • What sector is Crescent Capital BDC in?
  • What industry is Crescent Capital BDC in?
  • What country is Crescent Capital BDC based in?
  • When did Crescent Capital BDC go public?
  • Is Crescent Capital BDC in the S&P 500?
  • Is Crescent Capital BDC in the NASDAQ 100?
  • Is Crescent Capital BDC in the Dow Jones?
  • When was Crescent Capital BDC's last earnings report?
  • When does Crescent Capital BDC report earnings?
  • Should I buy Crescent Capital BDC stock now?

What is the primary business of Crescent Capital BDC?

Crescent Capital BDC (CCAP) is a business development company that provides financing solutions to middle-market companies. It focuses on private debt investments, including senior secured loans and subordinated debt, aiming to generate attractive risk-adjusted returns for its investors while supporting business growth.

What is the ticker symbol for Crescent Capital BDC?

The ticker symbol for Crescent Capital BDC is NASDAQ:CCAP

Does Crescent Capital BDC pay dividends?

Yes, Crescent Capital BDC pays dividends. The last payment was $0.42, with an ex-dividend date on 31 December 2024

What sector is Crescent Capital BDC in?

Crescent Capital BDC is in the Financial Services sector

What industry is Crescent Capital BDC in?

Crescent Capital BDC is in the Asset Management industry

What country is Crescent Capital BDC based in?

Crescent Capital BDC is headquartered in United States

When did Crescent Capital BDC go public?

Crescent Capital BDC's initial public offering (IPO) was on 03 February 2020

Is Crescent Capital BDC in the S&P 500?

No, Crescent Capital BDC is not included in the S&P 500 index

Is Crescent Capital BDC in the NASDAQ 100?

No, Crescent Capital BDC is not included in the NASDAQ 100 index

Is Crescent Capital BDC in the Dow Jones?

No, Crescent Capital BDC is not included in the Dow Jones index

When was Crescent Capital BDC's last earnings report?

Crescent Capital BDC's most recent earnings report was on 11 November 2024

When does Crescent Capital BDC report earnings?

The next expected earnings date for Crescent Capital BDC is 21 February 2025

Should I buy Crescent Capital BDC stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions